Cholesterol reducing agents inhibit assembly of type I parainfluenza viruses

Virology

Volumn 501, Issue , 2017, Pages 127-135

  Bajimaya, Shringkhala ^a   Hayashi, Tsuyoshi ^a   Frankl, Tünde ^a   Bryk, Peter ^a   Ward, Brian ^a   Takimoto, Toru ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Antiviral therapy; Assembly; Cholesterol; Lipid rafts; Type I parainfluenza virus

Indexed keywords

CHOLESTEROL; GEMFIBROZIL; M PROTEIN; MEVINOLIN; NUCLEOCAPSID PROTEIN; RAB11 PROTEIN; VIRUS GLYCOPROTEIN; HYPOCHOLESTEROLEMIC AGENT; VIRAL PROTEIN;

A549 CELL LINE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CELL SURFACE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PROTEIN INTERACTION; SENDAI VIRUS; VIROGENESIS; VIRUS ASSEMBLY; VIRUS RELEASE; VIRUS REPLICATION; CELL MEMBRANE; DRUG EFFECTS; GENETICS; METABOLISM; PARAMYXOVIRIDAE INFECTIONS; PHYSIOLOGY; PROTEIN TRANSPORT; VIROLOGY;

ANTICHOLESTEREMIC AGENTS; CELL MEMBRANE; CHOLESTEROL; HUMANS; PARAINFLUENZA VIRUS 1, HUMAN; PARAMYXOVIRIDAE INFECTIONS; PROTEIN TRANSPORT; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS RELEASE;

EID: 84999806644     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2016.11.011     Document Type: Article

References (48)

1. Ali, A., Nayak, D.P., Assembly of Sendai virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein. Virology 276 (2000), 289–303.
2. Ausubel, F.M., Short Protocols in Molecular Biology: A Compendium of Methods from Current Protocols in Molecular Biology. 3rd ed., 1995, Wiley, New York; Chichester.
3. Bialas, K.M., Desmet, E.A., Takimoto, T., Specific residues in the 2009 H1N1 swine-origin influenza matrix protein influence virion morphology and efficiency of viral spread in vitro. PLoS One, 7, 2012, e50595.
4. Brown, D.A., London, E., Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275 (2000), 17221–17224.
5. Brown, G., Aitken, J., Rixon, H.W., Sugrue, R.J., Caveolin-1 is incorporated into mature respiratory syncytial virus particles during virus assembly on the surface of virus-infected cells. J. Gen. Virol. 83 (2002), 611–621.
6. Brown, G., Jeffree, C.E., McDonald, T., Rixon, H.W., Aitken, J.D., Sugrue, R.J., Analysis of the interaction between respiratory syncytial virus and lipid-rafts in Hep2 cells during infection. Virology 327 (2004), 175–185.
7. Brown, G., Rixon, H.W., Sugrue, R.J., Respiratory syncytial virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1. J. Gen. Virol. 83 (2002), 1841–1850.
8. Budd, A., Alleva, L., Alsharifi, M., Koskinen, A., Smythe, V., Mullbacher, A., Wood, J., Clark, I., Increased survival after gemfibrozil treatment of severe mouse influenza. Antimicrob. Agents Chemother. 51 (2007), 2965–2968.
9. Chambers, R., Takimoto, T., Trafficking of Sendai virus nucleocapsids is mediated by intracellular vesicles. PLoS One, 5, 2010, e10994.
10. Chang, T.H., Segovia, J., Sabbah, A., Mgbemena, V., Bose, S., Cholesterol-rich lipid rafts are required for release of infectious human respiratory syncytial virus particles. Virology 422 (2012), 205–213.
11. Chazal, N., Gerlier, D., Virus entry, assembly, budding, and membrane rafts. Microbiol Mol. Biol. Rev. 67 (2003), 226–237.
12. del Real, G., Jimenez-Baranda, S., Mira, E., Lacalle, R.A., Lucas, P., Gomez-Mouton, C., Alegret, M., Pena, J.M., Rodriguez-Zapata, M., Alvarez-Mon, M., Martinez, A.C., Manes, S., Statins inhibit HIV-1 infection by down-regulating Rho activity. J. Exp. Med. 200 (2004), 541–547.
13. El Najjar, F., Schmitt, A.P., Dutch, R.E., Paramyxovirus glycoprotein incorporation, assembly and budding: a three way dance for infectious particle production. Viruses 6 (2014), 3019–3054.
14. Gerl, M.J., Sampaio, J.L., Urban, S., Kalvodova, L., Verbavatz, J.M., Binnington, B., Lindemann, D., Lingwood, C.A., Shevchenko, A., Schroeder, C., Simons, K., Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane. J. Cell Biol. 196 (2012), 213–221.
15. Gosselin-Grenet, A.S., Mottet-Osman, G., Roux, L., From assembly to virus particle budding: pertinence of the detergent resistant membranes. Virology 344 (2006), 296–303.
16. Govorkova, E.A., Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses. Influenza and Other Respir. Viruses 7:Suppl 1 (2013), S50–S57.
17. Gower, T.L., Graham, B.S., Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro. Antimicrob. Agents Chemother. 45 (2001), 1231–1237.
18. Harrison, M.S., Sakaguchi, T., Schmitt, A.P., Paramyxovirus assembly and budding: building particles that transmit infections. Int J. Biochem Cell Biol. 42 (2010), 1416–1429.
19. Harvala, H., Gaunt, E., McIntyre, C., Roddie, H., Labonte, S., Curran, E., Othieno, R., Simmonds, P., Bremner, J., Epidemiology and clinical characteristics of parainfluenza virus 3 outbreak in a Haemato-oncology unit. J. Infect. 65 (2012), 246–254.
20. Henrickson, K.J., Parainfluenza viruses. Clin. Microbiol Rev. 16 (2003), 242–264.
21. Holtta-Vuori, M., Tanhuanpaa, K., Mobius, W., Somerharju, P., Ikonen, E., Modulation of cellular cholesterol transport and homeostasis by Rab11. Mol. Biol. Cell 13 (2002), 3107–3122.
22. Ikeda, M., Abe, K., Yamada, M., Dansako, H., Naka, K., Kato, N., Different anti-HCV profiles of statins and their potential for combination therapy with interferon. Hepatology 44 (2006), 117–125.
23. Imhoff, H., von Messling, V., Herrler, G., Haas, L., Canine distemper virus infection requires cholesterol in the viral envelope. J. Virol. 81 (2007), 4158–4165.
24. Laliberte, J.P., McGinnes, L.W., Peeples, M.E., Morrison, T.G., Integrity of membrane lipid rafts is necessary for the ordered assembly and release of infectious Newcastle disease virus particles. J. Virol. 80 (2006), 10652–10662.
25. Liu, L., Oza, S., Hogan, D., Perin, J., Rudan, I., Lawn, J.E., Cousens, S., Mathers, C., Black, R.E., Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385 (2015), 430–440.
26. Lyles, D.S., Assembly and budding of negative-strand RNA viruses. Adv. Virus Res. 85 (2013), 57–90.
27. Manie, S.N., de Breyne, S., Vincent, S., Gerlier, D., Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J. Virol. 74 (2000), 305–311.
28. Mao, N., Ji, Y., Xie, Z., Wang, H., Wang, H., An, J., Zhang, X., Zhang, Y., Zhu, Z., Cui, A., Xu, S., Shen, K., Liu, C., Yang, W., Xu, W., Human parainfluenza virus-associated respiratory tract infection among children and genetic analysis of HPIV-3 strains in Beijing, China. PLoS One, 7, 2012, e43893.
29. Maron, D.J., Fazio, S., Linton, M.F., Current perspectives on statins. Circulation 101 (2000), 207–213.
30. Ono, A., Freed, E.O., Role of lipid rafts in virus replication. Adv. Virus Res. 64 (2005), 311–358.
31. Petersen, J., Drake, M.J., Bruce, E.A., Riblett, A.M., Didigu, C.A., Wilen, C.B., Malani, N., Male, F., Lee, F.H., Bushman, F.D., Cherry, S., Doms, R.W., Bates, P., Briley, K. Jr., The major cellular sterol regulatory pathway is required for Andes virus infection. PLoS Pathog., 10, 2014, e1003911.
32. Pohl, C., Duprex, W.P., Krohne, G., Rima, B.K., Schneider-Schaulies, S., Measles virus M and F proteins associate with detergent-resistant membrane fractions and promote formation of virus-like particles. J. Gen. Virol. 88 (2007), 1243–1250.
33. Ravid, D., Leser, G.P., Lamb, R.A., A role for caveolin 1 in assembly and budding of the paramyxovirus parainfluenza virus 5. J. Virol. 84 (2010), 9749–9759.
34. Robinzon, S., Dafa-Berger, A., Dyer, M.D., Paeper, B., Proll, S.C., Teal, T.H., Rom, S., Fishman, D., Rager-Zisman, B., Katze, M.G., Impaired cholesterol biosynthesis in a neuronal cell line persistently infected with measles virus. J. Virol. 83 (2009), 5495–5504.
35. Roy, A., Pahan, K., Gemfibrozil, stretching arms beyond lipid lowering. Immunopharmacol. Immunotoxicol. 31 (2009), 339–351.
36. Sanderson, C.M., Avalos, R., Kundu, A., Nayak, D.P., Interaction of Sendai viral F, HN, and M proteins with host cytoskeletal and lipid components in Sendai virus-infected BHK cells. Virology 209 (1995), 701–707.
37. Stone, R., Hayashi, T., Bajimaya, S., Hodges, E., Takimoto, T., Critical role of Rab11a-mediated recycling endosomes in the assembly of type I parainfluenza viruses. Virology 487 (2016), 11–18.
38. Stone, R., Takimoto, T., Critical role of the fusion protein cytoplasmic tail sequence in parainfluenza virus assembly. PLoS One, 8, 2013, e61281.
39. Strober, W., Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol. Append. 3, Append., 3B, 2001 Appendix 3, Appendix 3B.
40. Sun, X., Whittaker, G.R., Role for influenza virus envelope cholesterol in virus entry and infection. J. Virol. 77 (2003), 12543–12551.
41. Sydnor, E.R., Greer, A., Budd, A.P., Pehar, M., Munshaw, S., Neofytos, D., Perl, T.M., Valsamakis, A., An outbreak of human parainfluenza virus 3 infection in an outpatient hematopoietic stem cell transplantation clinic. Am. J. Infect. Control 40 (2012), 601–605.
42. Takahashi, M., Murate, M., Fukuda, M., Sato, S.B., Ohta, A., Kobayashi, T., Cholesterol controls lipid endocytosis through Rab11. Mol. Biol. Cell 18 (2007), 2667–2677.
43. Takahashi, T., Suzuki, T., Function of membrane rafts in viral lifecycles and host cellular response. Biochem. Res. Int., 2011, 2011, 245090.
44. Takimoto, T., Murti, K.G., Bousse, T., Scroggs, R.A., Portner, A., Role of matrix and fusion proteins in budding of Sendai virus. J. Virol. 75 (2001), 11384–11391.
45. Takimoto, T., Portner, A., Molecular mechanism of paramyxovirus budding. Virus Res. 106 (2004), 133–145.
46. van 't Wout, A.B., Lehrman, G.K., Mikheeva, S.A., O'Keeffe, G.C., Katze, M.G., Bumgarner, R.E., Geiss, G.K., Mullins, J.I., Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines. J. Virol. 77 (2003), 1392–1402.
47. Vincent, S., Gerlier, D., Manie, S.N., Measles virus assembly within membrane rafts. J. Virol. 74 (2000), 9911–9915.
48. Yeo, D.S., Chan, R., Brown, G., Ying, L., Sutejo, R., Aitken, J., Tan, B.H., Wenk, M.R., Sugrue, R.J., Evidence that selective changes in the lipid composition of raft-membranes occur during respiratory syncytial virus infection. Virology 386 (2009), 168–182.